Want to join the conversation?
Stifel Nicolaus analyst Drew Crum follows up asking for an explanation regarding the 10% sales growth seen in Education that didn't slow through the bottom line. $SCHL replies that throughout last year, the company added new people to really grow and make an investment in this business. So, there wasn't much of an impact of the adds in 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?